Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China · Delayed Price · Currency is CNY 18.46
+0.04 (0.22%)
Sep 18, 2026, 3:00 PM CST
SHA:600079 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 23,901 | 23,918 | 25,386 | 24,445 | 22,276 | 20,510 |
Other Revenue | 57.56 | 43.76 | 49.36 | 79.84 | 61.67 | 38.69 |
| 23,959 | 23,962 | 25,435 | 24,525 | 22,338 | 20,549 | |
Revenue Growth | -2.76% | -5.79% | 3.71% | 9.79% | 8.71% | -0.63% |
Cost of Revenue | 12,187 | 12,435 | 14,123 | 13,302 | 12,632 | 11,777 |
Gross Profit | 11,772 | 11,527 | 11,312 | 11,223 | 9,706 | 8,772 |
Selling, General & Admin | 6,273 | 6,195 | 6,563 | 6,168 | 5,827 | 5,327 |
Research & Development | 1,397 | 1,501 | 1,471 | 1,462 | 966.86 | 810.47 |
Other Operating Expenses | 282.44 | 212.6 | 140.36 | 202.61 | 205.86 | 224.56 |
Operating Expenses | 7,972 | 7,956 | 8,299 | 7,904 | 7,057 | 6,411 |
Operating Income | 3,800 | 3,571 | 3,014 | 3,319 | 2,649 | 2,361 |
Interest Expense | -225.12 | -271.04 | -351.37 | -354.14 | -476.57 | -602.15 |
Interest & Investment Income | 103.9 | 127.63 | 185.18 | 265.56 | 978.8 | 365.38 |
Currency Exchange Gain (Loss) | -163.2 | -30.92 | -23.2 | 45.96 | 123.67 | -58.34 |
Other Non Operating Income (Expenses) | -12.32 | -52.11 | -186.88 | -130.81 | 120.33 | -59.2 |
EBT Excluding Unusual Items | 3,503 | 3,345 | 2,637 | 3,146 | 3,395 | 2,007 |
Impairment of Goodwill | -332.06 | -332.06 | -206.98 | -26.15 | -35.33 | -42.68 |
Gain (Loss) on Sale of Investments | 12.11 | 11.82 | 50.08 | 136.85 | 43.42 | 7.89 |
Gain (Loss) on Sale of Assets | 55.45 | 52.75 | -16.29 | -4.14 | -51.51 | 26.06 |
Asset Writedown | -68.33 | -62.44 | -104.2 | -24.72 | -36.4 | -7.17 |
Other Unusual Items | 93.17 | 41.43 | 62.91 | 156.13 | 110.86 | 182.16 |
Pretax Income | 3,264 | 3,056 | 2,423 | 3,384 | 3,426 | 2,173 |
Income Tax Expense | 576.77 | 564 | 644.49 | 568.56 | 354.75 | 354.78 |
Earnings From Continuing Operations | 2,687 | 2,492 | 1,778 | 2,815 | 3,071 | 1,818 |
Minority Interest in Earnings | -656.62 | -637.12 | -448.6 | -680.78 | -587.19 | -501.05 |
Net Income | 2,030 | 1,855 | 1,330 | 2,134 | 2,484 | 1,317 |
Net Income to Common | 2,030 | 1,855 | 1,330 | 2,134 | 2,484 | 1,317 |
Net Income Growth | 47.83% | 39.53% | -37.70% | -14.07% | 88.60% | 30.96% |
Shares Outstanding (Basic) | 1,635 | 1,627 | 1,622 | 1,617 | 1,613 | 1,587 |
Shares Outstanding (Diluted) | 1,635 | 1,627 | 1,622 | 1,629 | 1,613 | 1,606 |
Shares Change | 1.07% | 0.36% | -0.47% | 1.01% | 0.42% | 16.59% |
EPS (Basic) | 1.24 | 1.14 | 0.82 | 1.32 | 1.54 | 0.83 |
EPS (Diluted) | 1.24 | 1.14 | 0.82 | 1.31 | 1.54 | 0.82 |
EPS Growth | 46.27% | 39.02% | -37.41% | -14.94% | 87.81% | 12.33% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2,048 | 1,786 | 1,143 | 8.93 | -672.27 | 475.78 |
Free Cash Flow Per Share | 1.25 | 1.10 | 0.70 | 0.01 | -0.42 | 0.30 |
Dividend Per Share | 0.480 | 0.480 | 0.470 | 0.460 | 0.160 | 0.150 |
Dividend Growth | 50.00% | 2.13% | 2.17% | 187.50% | 6.67% | 50.00% |
Gross Margin | 49.13% | 48.11% | 44.47% | 45.76% | 43.45% | 42.69% |
Operating Margin | 15.86% | 14.90% | 11.85% | 13.53% | 11.86% | 11.49% |
Profit Margin | 8.47% | 7.74% | 5.23% | 8.70% | 11.12% | 6.41% |
Free Cash Flow Margin | 8.55% | 7.45% | 4.50% | 0.04% | -3.01% | 2.31% |
EBITDA | 4,769 | 4,554 | 4,015 | 4,108 | 3,372 | 3,020 |
EBITDA Margin | 19.91% | 19.00% | 15.79% | 16.75% | 15.10% | 14.70% |
D&A For EBITDA | 969.25 | 982.64 | 1,002 | 788.75 | 723.08 | 659.23 |
EBIT | 3,800 | 3,571 | 3,014 | 3,319 | 2,649 | 2,361 |
EBIT Margin | 15.86% | 14.90% | 11.85% | 13.53% | 11.86% | 11.49% |
Effective Tax Rate | 17.67% | 18.45% | 26.60% | 16.80% | 10.35% | 16.33% |
Revenue as Reported | 23,959 | 23,962 | 25,435 | 24,525 | 22,338 | 20,549 |